Report error Found 385 Enz. Inhib. hit(s) with Target = 'Potassium voltage-gated channel subfamily KQT member 2'
TargetPotassium voltage-gated channel subfamily KQT member 2(Mouse)
Bristol-Myers Squibb
Curated by ChEMBL
Bristol-Myers Squibb
Curated by ChEMBL
Affinity DataEC50: 0.900nMAssay Description:Induction of mouse KCNQ2 expressed in HEK293 cells at -40 mV holding potential by whole-cell patch clamp assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Mouse)
Bristol-Myers Squibb
Curated by ChEMBL
Bristol-Myers Squibb
Curated by ChEMBL
Affinity DataEC50: 2.40nMAssay Description:Induction of mouse KCNQ2 expressed in HEK293 cells at -40 mV holding potential by whole-cell patch clamp assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 8nMAssay Description:Cell preparation: CHO-KCNQ2 cells were cultured in a 175 cm2 culture flask, and when the cells was grown to a density of 60-80%, the culture medium w...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Mouse)
Bristol-Myers Squibb
Curated by ChEMBL
Bristol-Myers Squibb
Curated by ChEMBL
Affinity DataEC50: 10nMAssay Description:Induction of mouse KCNQ2 expressed in HEK293 cells at -40 mV holding potential by whole-cell patch clamp assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Mouse)
Bristol-Myers Squibb
Curated by ChEMBL
Bristol-Myers Squibb
Curated by ChEMBL
Affinity DataEC50: 10nMAssay Description:Effect on outward potassium currents in whole-cell patch clamp assay of HEK 293 cells expressing cloned mouse KCNQ2 channel at -40 mVMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Mouse)
Bristol-Myers Squibb
Curated by ChEMBL
Bristol-Myers Squibb
Curated by ChEMBL
Affinity DataEC50: 20nMAssay Description:Induction of mouse KCNQ2 expressed in HEK293 cells at -40 mV holding potential by whole-cell patch clamp assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 20nMAssay Description:Channel opening activity at KCNQ2 (unknown origin) expressed in CHO cells after 10 mins by atomic absorption spectrophotometry-based Rb+ flow assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 20nMAssay Description:Human Kv7.2, Kv7.4 or Kv7.5/7.3 channels were evaluated using a voltage protocol in which cells were voltage-clamped at a holding potential of -60 mV...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Mouse)
Bristol-Myers Squibb
Curated by ChEMBL
Bristol-Myers Squibb
Curated by ChEMBL
Affinity DataEC50: 20nMAssay Description:Effect on outward potassium currents in whole-cell patch clamp assay of HEK 293 cells expressing cloned mouse KCNQ2 channel at -40 mVMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 20nMAssay Description:Human Kv7.2, Kv7.4 or Kv7.5/7.3 channels were evaluated using a voltage protocol in which cells were voltage-clamped at a holding potential of -60 mV...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 20nMAssay Description:Channel opening activity at KCNQ2 (unknown origin) expressed in CHO cells after 10 mins by atomic absorption spectrophotometry-based Rb+ flow assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 20nMAssay Description:Human Kv7.2, Kv7.4 or Kv7.5/7.3 channels were evaluated using a voltage protocol in which cells were voltage-clamped at a holding potential of -60 mV...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 23nMAssay Description:Cell preparation: CHO-KCNQ2 cells were cultured in a 175 cm2 culture flask, and when the cells was grown to a density of 60-80%, the culture medium w...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 30nMAssay Description:Channel opening activity at KCNQ2 (unknown origin) expressed in CHO cells after 10 mins by atomic absorption spectrophotometry-based Rb+ flow assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 34nMAssay Description:Channel opening activity at KCNQ2 (unknown origin) expressed in CHO cells after 10 mins by atomic absorption spectrophotometry-based Rb+ flow assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Rat)
Shanghai Institute of Materia Medica
Curated by ChEMBL
Shanghai Institute of Materia Medica
Curated by ChEMBL
Affinity DataEC50: 37nMAssay Description:Agonist activity at rat KCNQ2 channel expressed in CHO cells by patch clamp methodMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 40nMAssay Description:Channel opening activity at KCNQ2 (unknown origin) expressed in CHO cells after 10 mins by atomic absorption spectrophotometry-based Rb+ flow assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataIC50: 48nMAssay Description:Inhibition of Kv7.2 in human HEK293 cells incubated for 1 hr by thallium flux assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 49nMAssay Description:Cell preparation: CHO-KCNQ2 cells were cultured in a 175 cm2 culture flask, and when the cells was grown to a density of 60-80%, the culture medium w...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 50nMAssay Description:At the beginning of each assay, 20 μl of cell suspension was dispensed into each well of a multi-hole 384-well SyncroPatch chip by the onboard p...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 50nMAssay Description:Human Kv7.2, Kv7.4 or Kv7.5/7.3 channels were evaluated using a voltage protocol in which cells were voltage-clamped at a holding potential of -60 mV...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 50nMAssay Description:Agonist activity at Kv7.2 (unknown origin) assessed as shifting of voltage dependent activation to more negative potentials by SyncroPatch assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataIC50: 55nMAssay Description:Inhibition of Kv7.2 in human HEK293 cells incubated for 1 hr by thallium flux assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 57nMAssay Description:Cell preparation: CHO-KCNQ2 cells were cultured in a 175 cm2 culture flask, and when the cells was grown to a density of 60-80%, the culture medium w...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Mouse)
Bristol-Myers Squibb
Curated by ChEMBL
Bristol-Myers Squibb
Curated by ChEMBL
Affinity DataEC50: 60nMAssay Description:Effect on outward potassium currents in whole-cell patch clamp assay of HEK 293 cells expressing cloned mouse KCNQ2 channel at -40 mVMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Mouse)
Bristol-Myers Squibb
Curated by ChEMBL
Bristol-Myers Squibb
Curated by ChEMBL
Affinity DataEC50: 60nMAssay Description:Whole-cell patch-clamp on recombinant mouse KCNQ2 channels expressed in HEK 293 cells at -40 mVMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Mouse)
Bristol-Myers Squibb
Curated by ChEMBL
Bristol-Myers Squibb
Curated by ChEMBL
Affinity DataEC50: 60nMAssay Description:Induction of mouse KCNQ2 expressed in HEK293 cells at -40 mV holding potential by whole-cell patch clamp assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 60nMAssay Description:Human Kv7.2, Kv7.4 or Kv7.5/7.3 channels were evaluated using a voltage protocol in which cells were voltage-clamped at a holding potential of -60 mV...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 60nMAssay Description:Human Kv7.2, Kv7.4 or Kv7.5/7.3 channels were evaluated using a voltage protocol in which cells were voltage-clamped at a holding potential of -60 mV...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 65nMAssay Description:Cell preparation: CHO-KCNQ2 cells were cultured in a 175 cm2 culture flask, and when the cells was grown to a density of 60-80%, the culture medium w...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Rat)
Shanghai Institute of Materia Medica
Curated by ChEMBL
Shanghai Institute of Materia Medica
Curated by ChEMBL
Affinity DataIC50: 68.1nMAssay Description:Source (MLPCN Center Name): Johns Hopkins Ion Channel Center (JHICC_KCNQ2_Inh_HFCP_IWS_CRC) Center Affiliation: Johns Hopkins University, School of M...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Rat)
Shanghai Institute of Materia Medica
Curated by ChEMBL
Shanghai Institute of Materia Medica
Curated by ChEMBL
Affinity DataIC50: 69.9nMAssay Description:Source (MLPCN Center Name): Johns Hopkins Ion Channel Center (JHICC_KCNQ2_Inh_HFCP_IWS_CRC) Center Affiliation: Johns Hopkins University, School of M...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 70nMAssay Description:At the beginning of each assay, 20 μl of cell suspension was dispensed into each well of a multi-hole 384-well SyncroPatch chip by the onboard p...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 70nMAssay Description:Human Kv7.2, Kv7.4 or Kv7.5/7.3 channels were evaluated using a voltage protocol in which cells were voltage-clamped at a holding potential of -60 mV...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 70nMAssay Description:At the beginning of each assay, 20 μl of cell suspension was dispensed into each well of a multi-hole 384-well SyncroPatch chip by the onboard p...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataIC50: 70nMAssay Description:Antagonist activity at KCNQ2 expressed in CHO cells incubated for 3 mins by automated patch clamp assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 71nMAssay Description:Cell preparation: CHO-KCNQ2 cells were cultured in a 175 cm2 culture flask, and when the cells was grown to a density of 60-80%, the culture medium w...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 80nMAssay Description:Activation of human Kv7.2 expressed in CHO cells assessed as increase in channel current amplitude by whole cell patch clamp electrophysiology assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 88nMAssay Description:Cell preparation: CHO-KCNQ2 cells were cultured in a 175 cm2 culture flask, and when the cells was grown to a density of 60-80%, the culture medium w...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Rat)
Shanghai Institute of Materia Medica
Curated by ChEMBL
Shanghai Institute of Materia Medica
Curated by ChEMBL
Affinity DataIC50: 92.3nMAssay Description:Source (MLPCN Center Name): Johns Hopkins Ion Channel Center (JHICC_KCNQ2_Inh_HFCP_IWS_CRC) Center Affiliation: Johns Hopkins University, School of M...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 98nMAssay Description:Cell preparation: CHO-KCNQ2 cells were cultured in a 175 cm2 culture flask, and when the cells was grown to a density of 60-80%, the culture medium w...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 100nMAssay Description:Human Kv7.2, Kv7.4 or Kv7.5/7.3 channels were evaluated using a voltage protocol in which cells were voltage-clamped at a holding potential of -60 mV...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 100nMAssay Description:At the beginning of each assay, 20 μl of cell suspension was dispensed into each well of a multi-hole 384-well SyncroPatch chip by the onboard p...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Rat)
Shanghai Institute of Materia Medica
Curated by ChEMBL
Shanghai Institute of Materia Medica
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Source (MLPCN Center Name): Johns Hopkins Ion Channel Center (JHICC_KCNQ2_Inh_HFCP_IWS_CRC) Center Affiliation: Johns Hopkins University, School of M...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Mouse)
Bristol-Myers Squibb
Curated by ChEMBL
Bristol-Myers Squibb
Curated by ChEMBL
Affinity DataEC50: 120nMAssay Description:Effect on outward potassium currents in whole-cell patch clamp assay of HEK 293 cells expressing cloned mouse KCNQ2 channel at -40 mVMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 120nMAssay Description:Channel opening activity at KCNQ2 (unknown origin) expressed in CHO cells after 10 mins by atomic absorption spectrophotometry-based Rb+ flow assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 120nMAssay Description:At the beginning of each assay, 20 μl of cell suspension was dispensed into each well of a multi-hole 384-well SyncroPatch chip by the onboard p...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataIC50: 120nMAssay Description:Antagonist activity at KCNQ2 expressed in CHO cells incubated for 3 mins by automated patch clamp assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataEC50: 130nMAssay Description:Activation of KCNQ2 (unknown origin) expressed in CHO cells at 10 uM after 10 mins by atomic absorption spectrophotometry-based Rb+ flow assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily KQT member 2(Human)
Shanghai Zhimeng Biopharma
US Patent
Shanghai Zhimeng Biopharma
US Patent
Affinity DataIC50: 130nMAssay Description:Antagonist activity at KCNQ2 expressed in CHO cells incubated for 3 mins by automated patch clamp assayMore data for this Ligand-Target Pair














3D Structure (crystal)






























